clinical trial · NCT02527213
Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy
American Regent, Inc.·phase3·withdrawn
CalciphylaxisCalcific Uremic ArteriolopathySodium thiosulfatePlacebo
brief summary
To evaluate the efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase.
started
Jan 30, 2015
primary completion
Aug 29, 2016
completion
Aug 29, 2016
last updated
May 7, 2025
detailed description
Efficacy of Sodium Thiosulfate (STS) compared to placebo, in reducing analgesic requirement in subjects with calcific uremic arteriolopathy (CUA) during an initial 28-day treatment phase.
official title
Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol